ArticleCureus2026
Exquisite Radiosensitivity Leading to a Diagnosis of Ph+MPAL Mimicking Cerebrospinal Fluid Dissemination of Intraventricular Meningioma Following Stereotactic Radiotherapy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a rare case of Philadelphia chromosome-positive (Ph+) mixed phenotype acute leukemia (MPAL) that initially radiologically mimicked cerebrospinal fluid (CSF) dissemination after resection and subsequent stereotactic radiotherapy (SRT) for an intraventricular meningioma. A 77-year-old woman underwent resection of an asymptomatic World Health Organization grade I lateral ventricular meningioma. Due to residual tumor growth, the patient received three sessions of SRT for seven lesions between 28 and 45 months postoperatively. Two of these lesions were radiologically diagnosed as CSF dissemination of meningioma. At 63 months postoperatively, 2 new frontal lobe lesions appeared and were similarly treated with SRT (21 Gy in 3 fractions). Follow-up magnetic resonance imaging revealed complete resolution of these new lesions only two months after this low-dose SRT. This remarkably rapid response was inconsistent with the typical radiobiology of meningioma, prompting diagnostic reconsideration. The patient was subsequently diagnosed with Ph+MPAL. Although chemotherapy (prednisolone and dasatinib) was discontinued after one month due to adverse effects, the patient achieved complete remission. No recurrence of Ph+MPAL was observed for 23 months after the discontinuation of chemotherapy, until the patient died of causes unrelated to the primary disease. The unexpectedly exquisite radiosensitivity should prompt clinicians to reconsider the initial diagnosis. Such rapid responses may indicate underlying hematologic malignancies rather than slow-growing tumors like meningioma. Even in elderly patients, early detection can lead to successful remission with short-term treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.